首页> 外文会议>American Institute of Chemical Engineers annual meeting >(541 e) Integration of Signaling Networks with Differential Gene Regulation Data Using a Probabilistic Pathway Impact Analysis Approach
【24h】

(541 e) Integration of Signaling Networks with Differential Gene Regulation Data Using a Probabilistic Pathway Impact Analysis Approach

机译:(541 e)使用概率途径影响分析方法将信号网络与差异基因调控数据的集成

获取原文

摘要

The objective of the present study is to integrate the information on intracellular signaling network structures with large-scale gene expression data sets to predict functional changes in the cellular pathways that are operational under those conditions. Conventional approaches do not consider the network structure and transform the signaling pathway structures into lists of proteins, map the corresponding gene expression to these proteins and compute statistical confidence for observing these changes against a random chance. As the network structure is ignored in such 'enrichment'-based methods, the results do not reflect the biological constraints and are likely to be erroneous in typical use. For example, consider the case when only a single component of a pathway with 10 total nodes is significantly down-regulated. The biological significance is likely to be dependent on whether the down-regulated component is an activator or an inhibitor and its location in the pathway structure. However, conventional methods ignore this important connectivity information. Recently, a method named SPIA was proposed to overcome this issue by incorporating the signaling pathway structure explicitly in assessing the impact of gene expression changes on cellular function (Traca et al., Bioinformatics 2009). A limitation of SPIA is that it considers the canonical signaling pathways in its assessment and does not reflect the particular biological context from which the gene expression data was obtained.
机译:本研究的目的是将关于细胞内信令网络结构的信息与大规模基因表达数据集集成,以预测在这些条件下可操作的细胞途径中的功能变化。常规方法不考虑网络结构并将信号通路结构转化为蛋白质的列表,将相应的基因表达映射到这些蛋白质中,并计算统计置信度,以观察随机机会的这些变化。随着网络结构在这种“基于浓缩的方法中,结果不反映生物限制,并且在典型使用中可能是错误的。例如,考虑只有10个总节点的路径的单个组件显着下调。生物学意义可能依赖于下调组分是否是活化剂或抑制剂及其在途径结构中的位置。然而,传统方法忽略了这种重要的连接信息。最近,提出了一种名为SPIA的方法来克服该问题,通过在评估细胞功能对基因表达变化的影响时,通过明确地结合信号通路结构来克服这一问题(Traca等,生物信息学2009)。 Spia的限制是它考虑了其评估中的规范信号传导途径,并且不反映出基因表达数据的特定生物学背景。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号